John Lunger insider trades

Open-market stock purchases and sales by John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics plc, from SEC Form 4 filings since Aug 1, 2019.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ADAP Adaptimmune Therapeutics plc: 28 sales, last Feb 20, 2025
  • GNCA Genocea Biosciences, Inc: other filings, last Mar 3, 2022

Get free alerts when John Lunger files a new trade →